The Clinical and Demographic Characteristics of Our Cases with Primary Bone Tumors and Soft Tissue Tumors

Basit Öğe Kaydı
dc.contributor.authorOruc, Zeynep
dc.contributor.authorKaplan, Muhammet A.
dc.contributor.authorYerlikaya, Halis
dc.contributor.authorCelik, M. Ali
dc.contributor.authorOruc, Idris
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorKucukoner, Mehmet
dc.date.accessioned2024-04-24T17:24:47Z
dc.date.available2024-04-24T17:24:47Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe current study aimed to investigate the clinical and demographic characteristics of the patients with sarcoma who were treated and followed-up in Dicle University Medical Oncology Department. We retrospectively investigated the medical records of 547 patients who were diagnosed with sarcoma in the Dicle University School of Medicine, Department of Medical Oncology, between 2007 and 2015. When we considered the total number of patients (total 23,264) admitted to our center between 2007 and 2015, the rate of our patients with sarcoma was found to be 2.3% of this total number. Primary bone tumor and soft tissue sarcoma were determined in 32% (n=172) and 68% (n=375) of the patients, respectively. The most frequent histological type was osteosarcoma. The age, location of the primary tumor, adjuvant chemotherapy, location of relapse (local, metastatic), history of smoking, and comorbid diseases showed statistically significant differences between two groups. The overall survival and progression-free survival also did not differ significantly between the primary bone tumors and soft tissue tumors (p=0.65). The rate of our patients with sarcoma was 2.3% of the total number of patients (total 23,264) admitted to our center. This rate is higher than that in the literature. It is hard to interpret the results of the study, however it has been confirmed that the soft tissue sarcomas and primary bone tumors differ with regard to the age at diagnosis, location of tumor, location of relapse, prevalence of adjuvant chemotherapy and risk factors.en_US
dc.identifier.doi10.4999/uhod.161301
dc.identifier.endpage166en_US
dc.identifier.issn1306-133X
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84995807447
dc.identifier.scopusqualityQ4
dc.identifier.startpage159en_US
dc.identifier.trdizinid203452
dc.identifier.urihttps://doi.org/10.4999/uhod.161301
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/203452
dc.identifier.urihttps://hdl.handle.net/11468/19834
dc.identifier.volume26en_US
dc.identifier.wosWOS:000388276400005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.publisherAkad Doktorlar Yayinevien_US
dc.relation.ispartofUhod-Uluslararasi Hematoloji-Onkoloji Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSarcomaen_US
dc.subjectBone Tumoren_US
dc.subjectSoft Tissue Tumoren_US
dc.titleThe Clinical and Demographic Characteristics of Our Cases with Primary Bone Tumors and Soft Tissue Tumorsen_US
dc.titleThe Clinical and Demographic Characteristics of Our Cases with Primary Bone Tumors and Soft Tissue Tumors
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu